Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1312-2025Class II

Numerous models of nonsterile hemostatic forceps: (1) REF BH951R, Negus Tonsil Forceps HVY-CVD 190MM; (2) REF...

Aesculap Inc / initiated 2025-01-31 / Open, Classified / root cause: design

Aesculap Inc began a recall of Numerous models of nonsterile hemostatic forceps: (1) REF BH951R, Negus Tonsil Forceps HVY-CVD 190MM; (2) REF BH952R, Negus Tonsil Forceps X-HVY-CVD190MM; (3)... on . FDA classified it as Class II and gives the reason as "The forceps have been used in ways not covered by the design resulting in breakage of the clamps". As of , the recall status on record is Open, Classified, and MDM tags the root cause as design.

Recall record

Recall number
Z-1312-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Aesculap Inc
Product
Numerous models of nonsterile hemostatic forceps: (1) REF BH951R, Negus Tonsil Forceps HVY-CVD 190MM; (2) REF BH952R, Negus Tonsil Forceps X-HVY-CVD190MM; (3) REF BH957R, Schnidt Tonsil Forceps SLT-CVD185MM; (4) REF BH959R, Schnidt Tonsil Forceps CVD 185MM; (5) REF BH961R, Schnidt Tonsil FCPSOPEN-RINGCVD 185MM; (6) REF BH963R, Schnidt Tonsil FCPSOPEN-RINGCVD185MM; and (7) REF BH965R, Wilson Tonsil Forceps 190MM.
Product code
KAE Forceps, Ent
Reason for recall
The forceps have been used in ways not covered by the design resulting in breakage of the clamps.
Root cause tag
design
FDA root cause
Use error
Action
The recalling firm issued letters dated 1/29/2025 on 1/31/2025 via certified mail return-receipt. The letter explained the reason for the correction, identified the product impacted, provided the risk to health, and the actions required for the customer/user. The actions included: (1) Review the Urgent Medical Device Correction Notification in its entirety and ensure all users within the consignee organization are informed about the correction. Post the notification where the affected products are stored. If the consignee is a distributor, they are to forward the notification to their customers. The correction is to be extended to the end user/customer level; (2) Determine the current inventory of the affected items and comply with the following instructions: (a) Use the products identified for clamping of tissue and small vessels only; (b) Inspect the products for end-of-life indicators prior to use; (c) Visually inspect the products which should be clean and free of any signs of corrosion and cracks. Check the joint and jaw in the open position from both sides (if needed, use magnification; (d) Test the function of the device, including the jaw area, for deformation and loss of tension. An Acknowledgment Form was enclosed for completion and return via FAX or email within 2 weeks of receipt, even if the total inventory in the consignee location is 0.
Quantity in commerce
47,078 forceps
Distribution
Distribution was made nationwide and to PR. There was also government/military distribution. Foreign distribution was made to Canada, Bermuda, Bahamas, and Qatar.
Product codes and lots
GTIN numbers: (1) REF BH951R - 04038653027026; (2) REF BH952R - 04038653139200; (3) REF BH957R - 04038653027033; (4) REF BH959R - 04038653027040; (5) REF BH961R - 04038653027057; (6) REF BH963R - 04038653027064; and (7) REF BH965R - 04038653027071.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1312-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1308-2025Class IIOngoingVoluntary: Firm initiated
Z-1309-2025Class IIOngoingVoluntary: Firm initiated
Z-1310-2025Class IIOngoingVoluntary: Firm initiated
Z-1311-2025Class IIOngoingVoluntary: Firm initiated
Z-1312-2025Class IIOngoingVoluntary: Firm initiated